Sort   by:  
 Page size 
UnknownIdentifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030.
Not available
S-EPMC11663754 | biostudies-literature
UnknownThe cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children.
Not available
S-EPMC3428040 | biostudies-literature
UnknownConceptualizing the COVID-19 Pandemic: Perspectives of Pregnant and Lactating Women, Male Community Members, and Health Workers in Kenya.
Not available
S-EPMC9518350 | biostudies-literature
UnknownTrust in healthcare providers, information sources, and concerns for new maternal vaccines among pregnant and lactating women in Kenya.
Not available
S-EPMC12611154 | biostudies-literature
UnknownEvaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.
Not available
S-EPMC4806665 | biostudies-literature
UnknownImpact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.
Not available
S-EPMC4704666 | biostudies-literature
UnknownLive-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children.
Not available
S-EPMC7924568 | biostudies-literature
UnknownInfectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children.
Not available
S-EPMC11604081 | biostudies-literature
UnknownThe respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.
Not available
S-EPMC12311909 | biostudies-literature
UnknownLive Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.
Not available
S-EPMC5894088 | biostudies-literature
Sort   by:  
 Page size